Research shows that MAMs—tiny structures inside brain cells that act as communication hubs—may be a key cause of epilepsy and seizures, especially the drug-resistant kind. According to Gram Research analysis, when MAMs malfunction, they lose control over calcium levels, energy production, and cellular cleanup, triggering seizure development. New treatments targeting MAM function, including special diets and advanced drug delivery systems, could potentially help people whose seizures don’t respond to current medications.
Scientists are discovering that tiny structures inside brain cells called MAMs (mitochondria-associated endoplasmic reticulum membranes) may play a key role in causing epilepsy and seizures. According to Gram Research analysis, when these cellular communication hubs malfunction, they can trigger a chain reaction that leads to seizures—especially the kind that doesn’t respond to current medications. This review examines how MAMs control important cellular processes like calcium balance and stress management, and explores new treatment approaches including special diets, plant-based medicines, and advanced drug delivery systems that could target these structures to help people with drug-resistant epilepsy.
Key Statistics
A 2026 review in Molecular Neurobiology identified mitochondria-associated endoplasmic reticulum membranes (MAMs) as critical signaling hubs in epilepsy development, suggesting that MAM dysfunction may explain why approximately one-third of epilepsy patients don’t respond to standard seizure medications.
According to research reviewed by Gram, the ketogenic diet and certain plant-based compounds appear to improve MAM function and reduce seizures, indicating that multiple treatment approaches may work through a common mechanism of restoring cellular communication and energy production.
The 2026 review highlights that MAM abnormalities affect calcium signaling, lipid metabolism, mitochondrial dynamics, and autophagy—five core cellular processes that, when disrupted, can contribute to both seizure initiation and progression in drug-resistant epilepsy.
The Quick Take
- What they studied: How tiny structures inside brain cells called MAMs might cause epilepsy and seizures, and what new treatments could fix them
- Who participated: This is a review article that analyzed existing research rather than testing people directly. Scientists examined hundreds of studies about how MAMs work in the brain and epilepsy
- Key finding: MAMs act like communication centers in brain cells that control calcium levels, energy production, and stress responses. When MAMs break down, these processes fail and seizures can start—especially ones that don’t respond to regular seizure medications
- What it means for you: If you or someone you know has drug-resistant epilepsy, this research suggests new treatment options may be possible by fixing MAM function. However, these are still early-stage findings, and more testing in humans is needed before new treatments become available
The Research Details
This is a review article, which means scientists didn’t conduct new experiments on patients. Instead, they carefully read and analyzed hundreds of existing studies about how MAMs work in brain cells and how they relate to epilepsy. They looked at the molecular (tiny chemical) mechanisms that connect MAM problems to seizure development, and they examined current treatments like the ketogenic diet and plant-based medicines to understand how they might help MAMs work better.
The researchers organized their findings into categories: how MAMs control calcium (a chemical that triggers nerve signals), how they manage energy in cells, how they handle waste removal, and how they deal with harmful molecules called free radicals. They also reviewed new treatment ideas like special drugs, nanoparticles (super-tiny delivery systems), and brain stimulation technologies that could target MAMs directly.
This research approach is important because epilepsy affects millions of people worldwide, and about one-third don’t respond to current medications. By reviewing all available research together, scientists can see patterns and connections that individual studies might miss. Understanding MAMs as a central problem in epilepsy could lead to completely new types of treatments that work differently than current seizure medications, potentially helping people who currently have no good options.
This is a high-quality review published in a respected neuroscience journal. The authors systematically examined existing research and organized findings into a clear framework. However, because this is a review rather than new research, it doesn’t provide direct evidence from patient studies. The findings represent expert interpretation of existing data, so new experiments are needed to confirm whether MAM-targeting treatments actually work in people with epilepsy.
What the Results Show
The review identifies MAMs as critical control centers in brain cells that manage multiple processes related to seizures. When MAMs function normally, they carefully regulate calcium levels—calcium is essential for nerve signals but too much causes problems. They also help cells produce energy efficiently and remove damaged parts through a cleanup process called autophagy. When MAMs malfunction, calcium control breaks down, cells can’t make enough energy, and harmful molecules build up, all of which can trigger seizures.
The research shows that MAM problems appear especially important in drug-resistant epilepsy—the type where standard medications don’t work. This is significant because it suggests the root cause of drug resistance might be different from what current treatments target. By fixing MAM function instead of just blocking seizure signals, new treatments might work for people who don’t respond to existing drugs.
The review also identifies how several existing treatments may work by improving MAM function. The ketogenic diet (high fat, low carbohydrate) appears to help MAMs work better and reduce seizures. Certain plant-based compounds also seem to protect MAMs from damage. This suggests that MAM function is a common target that multiple different treatments can influence.
The research highlights that MAM problems connect to several other brain issues beyond just seizures, including problems with energy production, accumulation of toxic proteins, and excessive inflammation. These connections suggest that MAM-targeting treatments might help with multiple aspects of epilepsy rather than just stopping individual seizures. The review also identifies that genetic factors affecting MAM proteins may explain why some people develop epilepsy while others don’t, opening possibilities for personalized medicine approaches.
This review builds on growing recognition that mitochondria (cell powerhouses) play a major role in epilepsy. Previous research focused mainly on how seizures affect individual brain cells. This work expands that understanding by showing how MAMs—the connection points between mitochondria and other cellular structures—coordinate multiple processes that influence seizure development. The MAM-focused approach represents a shift from treating seizures as isolated electrical events to understanding them as problems in cellular communication and energy management.
As a review article, this work doesn’t provide direct evidence from testing treatments in people. The findings are based on laboratory studies and animal research, which don’t always translate to human treatment. Most MAM-targeting treatments mentioned (small molecules, nanoparticles, advanced brain stimulation) are still in early development stages and haven’t been tested in large human trials. Additionally, epilepsy is complex and involves many different causes, so fixing MAMs might help some patients but not others. More research is needed to determine which patients would benefit most from MAM-targeting approaches.
The Bottom Line
Current evidence suggests that maintaining healthy MAM function through existing approaches (like the ketogenic diet for appropriate patients, certain plant-based compounds, and standard seizure medications) may be beneficial. However, new MAM-targeting treatments are still experimental and not yet available for patient use. People with drug-resistant epilepsy should continue working with their neurologists on current treatment options while staying informed about emerging research. Confidence level: Moderate for existing treatments; Low for new experimental approaches.
People with epilepsy—especially those whose seizures don’t respond well to current medications—should find this research relevant. Family members and caregivers of people with epilepsy may also benefit from understanding this new perspective on how seizures develop. Neurologists and epilepsy specialists should pay attention to these findings when considering future treatment strategies. People without epilepsy don’t need to take action based on this research, though the findings may eventually lead to better treatments for everyone.
Existing treatments that may support MAM function (like the ketogenic diet) can show benefits within weeks to months. However, new MAM-targeting drugs and therapies are likely 5-10 years away from human testing, and potentially 10-15 years from becoming widely available. People shouldn’t expect immediate changes in treatment options, but this research suggests promising directions for future development.
Frequently Asked Questions
What are MAMs and why do they matter for epilepsy?
MAMs are connection points between mitochondria (cell powerhouses) and endoplasmic reticulum (cellular storage structures) that control calcium levels, energy production, and cellular cleanup. When MAMs malfunction, these processes fail and seizures can develop, especially drug-resistant seizures that don’t respond to current medications.
Can the ketogenic diet help with epilepsy by fixing MAM problems?
Research suggests the ketogenic diet may improve MAM function and reduce seizures in some people with epilepsy. The diet appears to help cells produce energy more efficiently and reduce harmful molecules, supporting better MAM performance. However, it doesn’t work for everyone and requires medical supervision.
When will new MAM-targeting epilepsy treatments be available?
New treatments targeting MAMs are still in early research stages and haven’t been tested in large human trials yet. Most experts estimate 5-10 years before human testing begins, with potentially 10-15 years before these treatments become widely available to patients.
Could MAM-targeting treatments help people with drug-resistant epilepsy?
Research suggests MAM-targeting approaches could potentially help drug-resistant epilepsy patients, since current medications don’t address MAM dysfunction. However, this remains theoretical—new treatments must be developed and tested in humans before we know if they actually work better than current options.
What can I do now to support healthy MAM function if I have epilepsy?
Work with your neurologist about the ketogenic diet if appropriate for your situation, maintain good sleep and stress management, and continue taking prescribed seizure medications. These approaches may support cellular health and MAM function, though more research is needed to confirm their specific benefits.
Want to Apply This Research?
- Track seizure frequency and severity weekly, along with diet type (if using ketogenic diet), sleep quality, and stress levels. Note any changes in these factors to identify patterns that correlate with seizure activity, which could help determine if MAM-supporting interventions are helping.
- If appropriate for your situation, work with your doctor to explore the ketogenic diet or other MAM-supporting approaches. Use the app to log meals, track adherence to dietary changes, and monitor how seizure patterns respond. Record any side effects or improvements to share with your healthcare team.
- Maintain a long-term seizure diary within the app, tracking not just seizure events but also factors that may affect MAM function: sleep patterns, stress, diet quality, exercise, and medication adherence. Over months, this data can reveal whether lifestyle changes supporting cellular health correlate with improved seizure control.
This article reviews scientific research about potential mechanisms in epilepsy development and emerging treatment approaches. It is not medical advice and should not replace consultation with a qualified neurologist or healthcare provider. If you have epilepsy or experience seizures, continue taking prescribed medications and work with your medical team before making any changes to your treatment plan. New treatments discussed in this research are experimental and not yet available for patient use. Always consult with a healthcare professional before starting new diets, supplements, or treatments.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.